REQUEST A DEMO
Total
USD $0.00
Search more companies

Sandoz Pharmaceuticals SRL (Romania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Sandoz Pharmaceuticals SRL Profile Updated: November 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sandoz Pharmaceuticals SRL coordinates the Romanian commercial and medical-affairs activities of Sandoz. The company markets and distributes generic medicines and biosimilar therapies across therapeutic areas including anti-infectives, cardiovascular care, oncology and hospital treatments. It works with healthcare institutions, pharmacies and wholesalers, ensuring regulatory compliance, medical information support and supply continuity for essential medicines.

Headquarters
Calea Floreasca Nr. 169a
Bucharest; Bucharest;

Contact Details: Purchase the Sandoz Pharmaceuticals SRL report to view the information.

Website: https://www.sandoz.com

Basic Information
Total Employees:
Purchase the Sandoz Pharmaceuticals SRL report to view the information.
Registered Capital:
Purchase the Sandoz Pharmaceuticals SRL report to view the information.
Financial Auditors:
Purchase the Sandoz Pharmaceuticals SRL report to view the information.
Incorporation Date:
October 25, 2022
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sandoz Pharmaceuticals SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
181.21%
Total operating revenue
180.88%
Operating profit (EBIT)
320.62%
EBITDA
261.27%
Net Profit (Loss) for the Period
N/A
Total Assets
46.39%
Total Equity
9.87%
Operating Profit Margin (ROS)
1.09%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?